Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers

por Song, W, Hwang, Y, Youngblood, V M, Cook, R S, Balko, J M, Chen, J, Brantley-Sieders, D M
Publicado 2017